Search research articles
Contact Us
Filters
Showing results (161-170 of 183) with videos related to
Page
of 19
Sort By:
JAMA
|
October 31, 2024
Differences in Drug Shortages in the US and Canada
Mina Tadrous, Katherine Callaway Kim, Inmaculada Hernandez, et al.
JAMA Network Open
|
July 27, 2021
Cost-effectiveness of Dapagliflozin for the Treatment of Heart Failure With Reduced Ejection Fraction
Nicolas Isaza, Paola Calvachi, Inbar Raber, et al.
JAMA Network Open
|
April 5, 2024
Drug Shortages Prior to and During the COVID-19 Pandemic
Katherine Callaway Kim, Scott D Rothenberger, Mina Tadrous, et al.
Diabetes, Obesity & Metabolism
|
September 2, 2021
Are novel glucose-lowering agents' cardiorenal benefits generalizable to individuals of Black race? A meta-trial sequential analysis to address disparities in cardiovascular and renal outcome trials enrolment
Huilin Tang, Stephen E Kimmel, Inmaculada Hernandez, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
June 10, 2023
A Real-World Evaluation of Primary Medication Nonadherence in Patients with Nonvalvular Atrial Fibrillation Prescribed Oral Anticoagulants in the United States
Inmaculada Hernandez, Victoria Divino, Lin Xie, et al.
Plos One
|
February 2, 2023
COVID-19 pandemic and trends in new diagnosis of atrial fibrillation: A nationwide analysis of claims data
Inmaculada Hernandez, Meiqi He, Jingchuan Guo, et al.
Diabetes, Obesity & Metabolism
|
March 4, 2025
Regional trends and disparities in newer GLP1 receptor agonist initiation among real-world adult patients eligible for obesity treatment
Rotana M Radwan, Yao An Lee, Pareeta Kotecha, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 20, 2025
Trends and Disparities in Newer GLP1 Receptor Agonist Initiation among Real-World Adult Patients Eligible for Obesity Treatment
Rotana M Radwan, Yao An Lee, Pareeta Kotecha, et al.
BMC Cardiovascular Disorders
|
December 9, 2023
COVID-19 pandemic and initiation of treatment for atrial fibrillation: a nationwide analysis of claims data
Lanting Yang, Shangbin Tang, Meiqi He, et al.
Nature Communications
|
September 11, 2020
Resolution of R-loops by INO80 promotes DNA replication and maintains cancer cell proliferation and viability
Lisa Prendergast, Urszula L McClurg, Rossitsa Hristova, et al.
Page
of 19
Search research articles
Search
Showing results (161-170 of 183) with videos related to
Sort By:
Page
of 19
JAMA
|
October 31, 2024
Differences in Drug Shortages in the US and Canada
Mina Tadrous, Katherine Callaway Kim, Inmaculada Hernandez, et al.
JAMA Network Open
|
July 27, 2021
Cost-effectiveness of Dapagliflozin for the Treatment of Heart Failure With Reduced Ejection Fraction
Nicolas Isaza, Paola Calvachi, Inbar Raber, et al.
JAMA Network Open
|
April 5, 2024
Drug Shortages Prior to and During the COVID-19 Pandemic
Katherine Callaway Kim, Scott D Rothenberger, Mina Tadrous, et al.
Diabetes, Obesity & Metabolism
|
September 2, 2021
Are novel glucose-lowering agents' cardiorenal benefits generalizable to individuals of Black race? A meta-trial sequential analysis to address disparities in cardiovascular and renal outcome trials enrolment
Huilin Tang, Stephen E Kimmel, Inmaculada Hernandez, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
June 10, 2023
A Real-World Evaluation of Primary Medication Nonadherence in Patients with Nonvalvular Atrial Fibrillation Prescribed Oral Anticoagulants in the United States
Inmaculada Hernandez, Victoria Divino, Lin Xie, et al.
Plos One
|
February 2, 2023
COVID-19 pandemic and trends in new diagnosis of atrial fibrillation: A nationwide analysis of claims data
Inmaculada Hernandez, Meiqi He, Jingchuan Guo, et al.
Diabetes, Obesity & Metabolism
|
March 4, 2025
Regional trends and disparities in newer GLP1 receptor agonist initiation among real-world adult patients eligible for obesity treatment
Rotana M Radwan, Yao An Lee, Pareeta Kotecha, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 20, 2025
Trends and Disparities in Newer GLP1 Receptor Agonist Initiation among Real-World Adult Patients Eligible for Obesity Treatment
Rotana M Radwan, Yao An Lee, Pareeta Kotecha, et al.
BMC Cardiovascular Disorders
|
December 9, 2023
COVID-19 pandemic and initiation of treatment for atrial fibrillation: a nationwide analysis of claims data
Lanting Yang, Shangbin Tang, Meiqi He, et al.
Nature Communications
|
September 11, 2020
Resolution of R-loops by INO80 promotes DNA replication and maintains cancer cell proliferation and viability
Lisa Prendergast, Urszula L McClurg, Rossitsa Hristova, et al.
Page
of 19